Scottrade.com
This email is compliments of Scottrade.com
If you would like to modify or suspend this alert, please login to your Scottrade account and navigate to the "Alerts" page under the "My Account" tab.
News for 'MSON' - (Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland)


FARMINGDALE, N.Y., Oct 07, 2009 /PRNewswire-FirstCall via COMTEX/ -- Misonix,
Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device
technology, which in Europe is used for the ablation of tumors and worldwide for
other acute health conditions, has entered into a new, three year, exclusive
distribution agreement with Neurotechnics Ltd., based in Banbury, England, for
the distribution of the BoneScalpel(TM) Ultrasonic Bone Cutter.

The agreement provides Neurotechnics with the rights to sell in the United
Kingdom and the Republic of Ireland, and includes minimum purchase requirements.

Neurotechnics is recognized as an innovative market leader in the distribution
of state-of-the-art medical devices and capital equipment, with special emphasis
in neuro and spine surgery.

The BoneScalpel is a tissue specific osteotomy device capable of making precise
cuts through bone and hard tissue while largely preserving delicate soft tissue
structures. It offers the convenience and speed of a power instrument without
the potential hazards associated with rotary sharps.

"Misonix welcomes Neurotechnics to our growing sales and distribution
organization. Neurotechnics comes to us with an established reputation as a
first tier distributor of advanced medical equipment in the United Kingdom and
Ireland," said Michael A. McManus, Jr., President and Chief Executive Officer of
Misonix.

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets
therapeutic ultrasonic medical devices and laboratory equipment. Misonix's
therapeutic ultrasonic platform is the basis for several innovative medical
technologies. Addressing a combined market estimated to be in excess of $3
billion annually; Misonix's proprietary ultrasonic medical devices are used for
wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and
other surgical and medical applications. Additional information is available on
the Company's Web site at www.misonix.com.